Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor (EBWL)
Obstetric Pain
About this trial
This is an interventional supportive care trial for Obstetric Pain focused on measuring obstetric pain, bupivacaine, analgesic efficacy
Eligibility Criteria
Inclusion Criteria:
- Women with normal pregnancy at term, with active labor, the American Society of Anesthesiologists physical (ASA) st atus I or II.
Exclusion Criteria:
- Patients with problems of language barriers, allergic to local anesthetics, which have been submitted in the last quarter of any of the following situations: pregnancy induced, placenta previa, abnormal fetal variety of presentation, cephalopelvic disproportion, uterine hypertonic hypertensive disease ; Obstetric emergencies such as severe preeclampsia, abruptio placenta detachment, acute fetal distress. Alterations in the anatomy of the spine or previous surgeries that prevent or restrict the conduct of epidural analgesia.
Sites / Locations
- Hospital General Regional número 17, Instituto Mexicano del Seguro Social.
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
bupivacaine 0.125%
bupivacaine 0.25%
administrate bupivacaine at 0.125% during initiation of effective labor work
Administrate bupivacaine at 0.25% during initiation of effective labor work One of the researchers selected from a randomized list containing pages in both groups with numbers ranging from 0001 to 0110 with 55 pages for each group and these selected folios prepared in sterile form and start the day in the morning, the amount of 10 10 ml syringes with foil for each mixture. The remaining samples were discarded if 10 analgesics are not achieved during the day, and the day new preparations were made.